Strongyloides Stercoralis Infection in Hispanic Veterans Living in Puerto Rico: A Tropical Issue or a Global One?


Journal

Puerto Rico health sciences journal
ISSN: 2373-6011
Titre abrégé: P R Health Sci J
Pays: Puerto Rico
ID NLM: 8303541

Informations de publication

Date de publication:
12 2021
Historique:
entrez: 25 1 2022
pubmed: 26 1 2022
medline: 23 4 2022
Statut: ppublish

Résumé

Strongyloidiasis is a parasitic infection classified by the World Health Organization as a neglected tropical disease. Although predominantly asymptomatic, it can become a life-threatening disease in an immunocompromised host. Epidemiologic studies in the Western Hemisphere are scarce, but even more scarce are descriptions of the natural course of this disease. Our objectives were to identify the different manifestations and outcomes of Strongyloides stercoralis infection in the Hispanic veteran population in Puerto Rico. We also discuss the importance of pursuing a timely diagnosis in high-risk patients migrating from or traveling to endemic areas, regardless of their symptomatic status. This was a single-center, retrospective record review study involving patients diagnosed with S. stercoralis via serology, stool samples, or organ biopsies, from 2008 through 2014. A total of 270 patients tested positive; 210 (77.8%) were asymptomatic. The mean age at diagnosis was 75.4 years old. Symptomatic patients had pulmonary (n = 25), gastrointestinal (n = 21), and dermatologic (n = 5) symptoms; 9 had multiple symptoms. Five had hyperinfection, mostly after treatment with systemic steroids or preexisting immunosuppression. The most common laboratory abnormality was eosinophilia. Reasons for testing were eosinophilia, asthma, diarrhea, screening for parasites, and unexplained skin rash. Our study highlights the importance of being aware of this potentially fatal infection, especially when treating patients traveling from endemic countries. It also highlights the importance of timely screening, diagnosis, and treatment of S. stercoralis infection in order to prevent potentially fatal outcomes, especially when considering immunosuppressive drugs.

Identifiants

pubmed: 35077076

Substances chimiques

Ivermectin 70288-86-7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

174-179

Auteurs

Javier A Cerra-Franco (JA)

Department of Medicine, Division of Gastroenterology, VA Caribbean Healthcare System, San Juan, PR.

Pedro Rosa-Cortés (P)

Department of Medicine, Division of Gastroenterology, VA Caribbean Healthcare System, San Juan, PR.

Rodolfo Estremera-Marcial (R)

Department of Medicine, Division of Gastroenterology, VA Caribbean Healthcare System, San Juan, PR.

Antonio Soto-Ramos (A)

Department of Medicine, Division of Gastroenterology, VA Caribbean Healthcare System, San Juan, PR.

Sonia Saavedra (S)

Department of Medicine, Division of Infectious Diseases, VA Caribbean Healthcare System, San Juan, PR.

Doris Toro (D)

Department of Medicine, Division of Gastroenterology, VA Caribbean Healthcare System, San Juan, PR.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH